FDA links rare cancer to textured breast implants and urges women to monitor themselves for possible symptoms.
Shantell M. Kirkendoll
Shantell M. Kirkendoll is the senior communication representative for the University of Michigan Health System. She leverages social media and media relations to tell compelling stories about research and health care. She was a Knight Journalism Fellow at the Centers for Disease Control and Prevention and joined the University of Michigan Health System in 2009. Prior to that she was a print journalist for 20 years.
Latest clinical trial brings study drug a step closer to FDA approval
Large Kellogg Eye Center study shows cases of herpes zoster ophthalmicus tripled in 12 year time span, highest among older adults
A Kellogg Eye Center study finds great promise in corneal transplants for patients who suffer shingles and develop subsequent vision-limiting corneal scarring.
Advances in gene therapy are yielding new options for treating inherited retinal degenerations, giving specialists new tools — and new hope for patients and families.
Nearly one-third of younger women without a known cancer risk receive the screening before breast reduction surgery, a test that can do more harm than good.